Reduction in current Russian Central Bank rates low probable under current inflation: Uliukaev

YEREVAN, December 12 . /ARKA/. Head of Russia’s ministry of economic development Aleksey Uliukaev said Russian Central Bank’s rates for key transactions will most probable not reduce under the current inflation, Uliukaev told reporters in London as quoted by RIA Novosti.

Directors’ board of Bank of Russia, as expected, maintained the key weekly auction REPO rate unchanged – at 5.5% per annum. The next rate policy meeting of the board is scheduled for December 13.

Russia’s inflation gained 6.1% from the beginning of the year till December 9, RosState reported Wednesday.–0–

spot_img

POPULAR

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img